Opaleye Management Inc. Eton Pharmaceuticals, Inc. Transaction History

Opaleye Management Inc.

$364 Million
Q1 2025

A detailed history of Opaleye Management Inc. transactions in Eton Pharmaceuticals, Inc. stock. As of the latest transaction made, Opaleye Management Inc. holds 2,852,070 shares of ETON stock, worth $44.5 Million. This represents 10.18% of its overall portfolio holdings.

Number of Shares

2,852,070

Previous 2,852,070 -0.0%

Holding current value

$44.5 Million

Previous $37.5 Million 1.29%

% of portfolio

10.18%

Previous 7.38%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$5.9 - $13.15 $425,213 - $947,720	72,070 Added 2.59%	2,852,070 $37.5 Million
Q3 2024 Nov 14, 2024	BUY	$3.28 - $6.0 $1.26 Million - $2.31 Million	385,000 Added 16.08%	2,780,000 $16.7 Million
Q2 2024 Aug 14, 2024	SELL	$3.06 - $3.75 $155,389 - $190,428	-50,781 Reduced 2.08%	2,395,000 $7.88 Million
Q1 2024 May 15, 2024	SELL	$3.48 - $5.03 $292,688 - $423,053	-84,106 Reduced 3.32%	2,445,781 $9.17 Million
Q4 2023 Feb 14, 2024	BUY	$3.45 - $4.66 $343,678 - $464,215	99,617 Added 4.1%	2,529,887 $11.1 Million
Q3 2023 Nov 14, 2023	BUY	$2.55 - $5.63 $370,438 - $817,870	145,270 Added 6.36%	2,430,270 $10.1 Million
Q2 2023 Aug 14, 2023	BUY	$3.32 - $4.04 $332,000 - $404,000	100,000 Added 4.58%	2,285,000 $7.97 Million
Q1 2023 May 12, 2023	BUY	$2.89 - $4.1 $43,350 - $61,499	15,000 Added 0.69%	2,185,000 $8.41 Million
Q4 2022 Feb 10, 2023	SELL	$2.02 - $3.25 $709,020 - $1.14 Million	-351,000 Reduced 13.92%	2,170,000 $6.12 Million
Q3 2022 Nov 14, 2022	BUY	$2.04 - $3.03 $119,340 - $177,255	58,500 Added 2.38%	2,521,000 $5.29 Million
Q2 2022 Aug 15, 2022	BUY	$2.55 - $4.38 $212,223 - $364,525	83,225 Added 3.5%	2,462,500 $6.45 Million
Q1 2022 May 16, 2022	SELL	$3.43 - $4.69 $19,636 - $26,850	-5,725 Reduced 0.24%	2,379,275 $10.4 Million
Q4 2021 Feb 14, 2022	SELL	$3.66 - $6.59 $2.57 Million - $4.63 Million	-703,100 Reduced 22.77%	2,385,000 $10.2 Million
Q3 2021 Nov 16, 2021	SELL	$4.2 - $6.26 $2.54 Million - $3.78 Million	-604,500 Reduced 16.37%	3,088,100 $15.6 Million
Q2 2021 Aug 16, 2021	SELL	$5.71 - $8.85 $1.98 Million - $3.07 Million	-347,400 Reduced 8.6%	3,692,600 $29.3 Million
Q4 2020 Feb 12, 2021	BUY	$6.65 - $8.83 $2.66 Million - $3.53 Million	400,000 Added 10.99%	4,040,000 $32.8 Million
Q1 2020 May 15, 2020	BUY	$2.87 - $7.47 $6.23 Million - $16.2 Million	2,170,544 Added 147.71%	3,640,000 $14.9 Million
Q4 2019 Feb 14, 2020	BUY	$5.59 - $7.2 $1.7 Million - $2.19 Million	304,456 Added 26.13%	1,469,456 $10.6 Million
Q3 2019 Nov 14, 2019	BUY	$5.19 - $8.72 $467,100 - $784,800	90,000 Added 8.37%	1,165,000 $7.36 Million
Q2 2019 Aug 14, 2019	BUY	$7.1 - $8.39 $2.2 Million - $2.6 Million	310,227 Added 40.56%	1,075,000 $8.49 Million
Q1 2019 May 15, 2019	BUY	$5.72 - $8.0 $1.38 Million - $1.93 Million	241,773 Added 46.23%	764,773 $6.12 Million
Q4 2018 Feb 14, 2019	BUY	$5.79 - $6.68 $3.03 Million - $3.49 Million	523,000 New	523,000 $3.2 Million

Others Institutions Holding ETON

# of Institutions

Shares Held

14M

Call Options Held

61.2K

Put Options Held

33.1K

View Full List

About Eton Pharmaceuticals, Inc.

Ticker ETON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,297,000
Market Cap $395M
Description
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...

More about ETON

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Opaleye Management Inc. with notifications on news.

Account

Opaleye Management Inc. Eton Pharmaceuticals, Inc. Transaction History